NEW YORK (GenomeWeb) – Great Basin today reported a 51 percent jump in its fourth quarter revenues on an increase in sales of the company's Clostridium difficile tests. 

For the three months ended Dec. 31, 2014, the Salt Lake City-based firm posted $445,283 in revenues, up from $295,785 for Q4 a year ago. Sales of its C. diff tests resulted from a bump up in the number of the company's customers, Great Basin said, adding it had 84 customers at the end of Q4. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.